Economics evaluation of alendronate versus ibandronate for postmenopausal osteoporosis in local community hospitals.

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: HUANG, Hsiao-Feng (Chi Mei Hospital, Chiali, Tainan, China Taiwan)
  • Co-author(s): Hsiao-Feng Huang
  • Abstract:

    Background

    In Taiwan, the medical costs in osteoporosis of postmenopausal women has a high socioeconomic impact on the individual and national health insurance. Bisphosphonates remain the mainstay for the treatment of osteoporosis in postmenopausal women and their effectiveness and costs vary considerably.

    Purpose

    The aims of the study were to..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login